Search Results - "Weiner, Amber K."

Subtelomeric CTCF and cohesin binding site organization using improved subtelomere assemblies and a novel annotation pipeline by Stong, Nicholas, Deng, Zhong, Gupta, Ravi, Hu, Sufen, Paul, Shiela, Weiner, Amber K, Eichler, Evan E, Graves, Tina, Fronick, Catrina C, Courtney, Laura, Wilson, Richard K, Lieberman, Paul M, Davuluri, Ramana V, Riethman, Harold

“…Mapping genome-wide data to human subtelomeres has been problematic due to the incomplete assembly and challenges of low-copy repetitive DNA elements. Here, we…”
Get full text

High-Quality Genome Assemblies Reveal Long Non-coding RNAs Expressed in Ant Brains by Shields, Emily J., Sheng, Lihong, Weiner, Amber K., Garcia, Benjamin A., Bonasio, Roberto

“…Ants are an emerging model system for neuroepigenetics, as embryos with virtually identical genomes develop into different adult castes that display diverse…”
Get full text

Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma by Mooney, Brian, Negri, Gian Luca, Shyp, Taras, Delaidelli, Alberto, Zhang, Hai-Feng, Spencer Miko, Sandra E, Weiner, Amber K, Radaoui, Alexander B, Shraim, Rawan, Lizardo, Michael M, Hughes, Christopher S, Li, Amy, El-Naggar, Amal M, Rouleau, Melanie, Li, Wei, Dimitrov, Dimiter S, Kurmasheva, Raushan T, Houghton, Peter J, Diskin, Sharon J, Maris, John M, Morin, Gregg B, Sorensen, Poul H

“…Ewing sarcoma is the second most common bone sarcoma in children, with 1 case per 1.5 million in the United States. Although the survival rate of patients…”
Get full text

Graphical Interpretation and Analysis of Proteins and their Ontologies (GiaPronto): A One-Click Graph Visualization Software for Proteomics Data Sets by Weiner, Amber K., Sidoli, Simone, Diskin, Sharon J., Garcia, Benjamin A.

“…Here we present a free interactive web tool to process and visualize proteomics data sets with a single click. GiaPronto can process all proteomics…”
Get full text

Advancing childhood cancer research through young investigator and advocate collaboration by Weiner, Amber K, Palmer, Antonia, Moll, Melanie Frost, Lindberg, Gavin, Reidy, Kevin, Diskin, Sharon J, Mackall, Crystal L, Maris, John M, Sullivan, Patrick J

Get full text

Abstract 2633: Advancing childhood cancer research through young investigator and advocate collaboration by Weiner, Amber K., Lindberg, Gavin, Moll, Melanie, Palmer, Antonia, Reidy, Kevin, Diskin, Sharon J., Mackall, Crystal L., Maris, John M., Sullivan, Patrick J.

“…Background: Cancer advocates and researchers share the same goal of driving science forward to create new therapies to cure more patients. The power of…”
Get full text

Abstract 684: Integrative proteomics and transcriptomics to define the cell surface landscape of neuroblastoma by Weiner, Amber K., Sidoli, Simone, Glisovic-Aplenc, Tina, Maris, John M., Garcia, Benjamin A., Diskin, Sharon J.

“…BACKGROUND. Neuroblastoma (NB) is an embryonal tumor of the sympathetic nervous system that accounts for 12% of childhood cancer deaths. Despite intense…”
Get full text

Abstract 3650: Integrative mass spectrometry and RNA-sequencing identifies DLK1 as a candidate immunotherapeutic target in neuroblastoma by Weiner, Amber K., Radaoui, Alexander B., Kendsersky, Nathan M., Harenza-Rokita, Jo Lynne, Sidoli, Simone, Conkrite, Karina L., Vaksman, Zalman, Rathi, Komal, Raman, Pichai, Martinez, Daniel, Bhatti, Tricia, Tsang, Matthew, Pawel, Bruce, Garcia, Benjamin A., Maris, John M., Diskin, Sharon J.

“…BACKGROUND. Neuroblastoma (NB) is an embryonal tumor of the sympathetic nervous system that accounts for 12% of childhood cancer deaths. Despite multimodal…”
Get full text

Abstract LB-B04: A multi-omic surfaceome study identifies DLK1 as an epigenetically regulated protein and immunotherapeutic target in neuroblastoma by Weiner, Amber K., Radaoui, Alexander B., Tsang, Matthew, Martinez, Dan, Sidoli, Simone, Conkrite, Karina L., Delaidelli, Alberto, Rokita, Jo Lynne, Lane, Maria V., Vaksman, Zalman, Rathi, Komal S., Raman, Pichai, Pogoriler, Jennifer, Bhatti, Tricia, Pawel, Bruce, Teicher, Beverly, Erickson, Stephen W., Sorensen, Poul, Mosse, Yael P., Krytska, Kateryna, Zammarchi, Francesca, Berkel, Patrick H. van, Smith, Malcolm A., Garcia, Benjamin A., Maris, John M., Diskin, Sharon J.

“…Background: Neuroblastoma (NB) is an embryonal tumor of the sympathetic nervous system that accounts for 12% of childhood cancer deaths. While the introduction…”
Get full text

Abstract 2012: A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate (ADC) demonstrates potent cytotoxicity in neuroblastoma (NBL) and fusion positive rhabdomyosarcoma (FP RMS) by Guerra, Alberto D., Kennedy, Annie, Adams, Cynthia, Shraim, Rawan, Weiner, Amber K., Chen, Chuan, Krytska, Kateryna, Larmour, Colleen, Matkar, Smita, Dimitrov, Dimiter, Jelev, Dontcho V., Mossé, Yael P.

“…Introduction: ALK is a lineage restricted oncoprotein expressed on the cell surface of NBL as wild-type (WT), mutated, or amplified, and recently shown to be…”
Get full text

Abstract 1090: GPC2 directed CAR T cells are efficacious against fusion-positive and fusion-negative rhabdomyosarcomas by Shraim, Rawan, Schuerch, Patrick M., Giudice, Anna Maria, Conkrite, Karina L., Weiner, Amber K., Radaoui, Alexander B., Mooney, Brian, Kurmasheva, Raushan T., Houghton, Peter J., Morin, Gregg B., Mosse, Yael B., Sorensen, Poul H., Garcia, Benjamin A., Sacan, Ahmet, Maris, John M., Bosse, Kristopher R., Diskin, Sharon J.

“…Background: Rhabdomyosarcoma (RMS) is an aggressive pediatric solid tumor with poor survival and new targeted therapies are needed. Aims: Using an integrative…”
Get full text

Abstract A009: Proteogenomic prioritization of immunotherapeutic targets in rhabdomyosarcoma nominate MEGF10 for preclinical development by Shraim, Rawan, Weiner, Amber K., Conkrite, Karina L., Radaoui, Alexander B., Maris, John M., Mosse, Yael P., Diskin, Sharon J., Sacan, Ahmet, Garcia, Benjamin A., Houghton, Peter J., Kurmasheva, Raushan T., Sorensen, Poul, Morin, Gregg B., Mooney, Brian

“…Background: Rhabdomyosarcoma (RMS) has a high unmet need in terms of precision therapy development as there are currently no approved immunotherapies or…”
Get full text

Abstract 4515: PIONEER: harnessing multi-omics data to enhance immunotherapeutic target discovery and development by Weiner, Amber K., Murali, Hemma, Shraim, Rawan, Conkrite, Karina L., Radaoui, Alexander B., Martinez, Daniel, Mooney, Brian, Spencer Miko, Sandra E., Negri, Gian, Delaidelli, Alberto, de Jong, Caitlyn, Zhu, Yuankun, Heath, Allison P., Pogoriler, Jennifer, Mosse, Yael P., Taylor, Deanne M., Sorensen, Poul H., Morin, Gregg B., Garcia, Benjamin A., Maris, John M., Diskin, Sharon J.

“…Introduction: Immunotherapeutic strategies have produced remarkable results in some malignancies. However, optimal cell surface targets in many childhood…”
Get full text